Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis

The cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout remains equivocal. Febuxostat had a better safety outcome compared with allopurinol. In this systematic review and meta‐analysis, we searched MEDLINE and Embase for articles published between March 1, 2000 and...

Full description

Saved in:
Bibliographic Details
Published in:Clin Cardiol
Main Authors: Gao, Linggen, Wang, Bin, Pan, Ying, Lu, Yan, Cheng, Rui
Format: Artigo
Language:Inglês
Published: Wiley Periodicals, Inc. 2021
Subjects:
Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259158/
https://ncbi.nlm.nih.gov/pubmed/34013998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23643
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items